Home  >  News
 Premier Research India
you can get e-magazine links on WhatsApp. Click here
Health & Insurance + Font Resize -

Orange Health Diagnostic Lab acquires Gurugram based Rapidx to enhance NCR footprint

Our Bureau, Bengaluru
Thursday, August 11, 2022, 14:30 Hrs  [IST]

Orange Health, a leading health-tech start-up diagnostic lab service, has acquired Gurugram-based Rapidx, a fast-growing diagnostic lab in a bid to expand its footprints in the crucial NCR region.

The current acquisition is a part of Orange Health’s strategy to accelerate growth, expand its reach and consolidate its position in the $10 billion diagnostic sector in India. The company was set up health-tech experts Dhruv Gupta and Tarun Bhambra, The start-up has innovated on its supply chain and processes to deliver reports from its NABL accredited and ICMR approved labs in just 6 hours post the sample drawing. The customers can get tested for a wide range of diagnostic tests, in just 60 minutes, in the comfort of their home, from 6:30 am to 10 pm, 7 days a week.

Coming close on the heels of its Series B funding, Orange Health’s latest acquisition will now enable them to deliver and expand its flagship service in the northern region of the country.

Commenting on the acquisition, Gupta and Bhambra, said, “The first and foremost consumer need in diagnostics space is access and convenience at affordable prices, particularly for those who are unwell and anxious. We feel that on-demand and at-home service will be the next leap in this sector from the current hyperlocal sample collection centres. This requires building an intelligent and robust supply chain and lab operations that not just promises speed but also on-time delivery. With the current acquisition, we aim to further expand our services and continue to offer 60 minute home collection and 6 hour reporting.

Orange Health will leverage Rapidx’s infrastructure and familiarity with Gurugram and Delhi to strengthen its foothold further. The company has already started investments to augment automation in Rapidx’s current lab and is in the process of launching at least more labs in the coming months.

According to Dr. Amit Arora, Kishore Gemini, and Dr. Dipti Ekka, co-founders of Rapidx, “After the second wave of Covid pandemic, we at Rapidx were exploring possibilities to make a shift in our business from B2B (business to business) to B2C (business to consumer). Orange Health was a strategic fit, given the shared vision and commitment to serving the diagnostics needs of a larger population. The acquisition will give us access to a unique consumer play and complement our skills and efforts to realise this combined vision.”

Rapidx’s advanced reference laboratory set up in Flow Cytometry, Immunofluorescence, and ELISA tests will add to Orange Health’s diagnostics services now.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |